West Pharmaceutical Services Engaging in Investor Conferences
West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, has announced its participation in several upcoming investor conferences. These events are an opportunity for the company to connect with investors, showcasing their cutting-edge capabilities in the pharmaceutical sector.
Scheduled Conferences
West Pharmaceutical will attend the following notable conferences this November:
UBS Global Healthcare Conference
The UBS Global Healthcare Conference will be held in California on November 12. West Pharmaceutical Services is scheduled to present at 3:30 PM PST. This conference focuses on key developments in the healthcare sector, providing insights into the industry.
Jefferies Healthcare Conference
On November 19, West will take part in the Jefferies Healthcare Conference in London, UK, at 1:00 PM GMT. This event aims to facilitate discussions around innovative healthcare solutions and investment opportunities within the market.
Stephens Annual Investment Conference
Finally, on November 21, the Stephens Annual Investment Conference will take place in Nashville. West Pharmaceutical is set to present at 10:00 AM CST, further solidifying its commitment to engaging with key stakeholders in the healthcare investment community.
Webcast Availability
Investors and interested parties can catch a live audio webcast of these presentations in the Investors section of the company’s website. After the events conclude, a replay of the webcasts will be accessible for about 90 days, allowing those who could not attend the conferences to stay informed.
About West Pharmaceutical Services
West Pharmaceutical Services, Inc. has established itself as a prominent provider of high-quality injectable solutions and services. They serve as a trusted partner for both established and emerging drug developers, ensuring that the containment and delivery of critical medicines are safe and effective. The company boasts a workforce of around 10,000 employees spread across 50 sites globally, delivering approximately 43 billion components and devices annually.
Financial Performance
In the recent fiscal year, West Pharmaceutical generated net sales of $2.95 billion, a testament to its strong market presence and strategic operations. The company is publicly traded on the New York Stock Exchange under the ticker symbol WST and is included in the prestigious Standard & Poor's 500 index.
Conclusion
West Pharmaceutical's participation in these investor conferences illustrates its ongoing commitment to transparency and engagement with its investors. By actively sharing its insights and innovative solutions, West aims to foster stronger relationships within the investor community, highlighting its role in advancing healthcare solutions.
Frequently Asked Questions
What is the purpose of West Pharmaceutical's participation in these conferences?
West Pharmaceutical's participation aims to showcase innovative solutions, engage with investors, and discuss industry advancements.
Where can I watch the webcasts of the presentations?
The live audio webcasts will be available on West Pharmaceutical's official website in the Investors section.
How many employees does West Pharmaceutical have?
West Pharmaceutical has approximately 10,000 team members across 50 global locations.
What are the upcoming conference dates for West Pharmaceutical?
West is scheduled to present at the UBS Global Healthcare Conference on November 12, Jefferies Healthcare Conference on November 19, and Stephens Annual Investment Conference on November 21.
What is West Pharmaceutical's ticker symbol?
West Pharmaceutical Services, Inc. is traded under the ticker symbol WST on the New York Stock Exchange.